Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Jose A. Martinez-Climent,Am Comes,Esperanza Vizcarra,I Benet,Cristina Arbona,Felipe Prosper,C Solano,B. García Clavel,Isabel Marugán,Ana Lluch,Javier García-Conde

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

2000

Jose A. Martinez-Climent
Am Comes
Esperanza Vizcarra
I Benet
Cristina Arbona
Felipe Prosper
C Solano
B. García Clavel
Isabel Marugán
Ana Lluch
Javier García-Conde

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome

Keywords:

Cancer
Bone marrow
Stem cell
Immunology
Breast cancer
Medicine
Leukemia
Aneuploidy
Autologous stem-cell transplantation
Cytogenetics
Transplantation
Adjuvant therapy
Population

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations